drugset / Trial / NCT00513981
High-Dose Methotrexate in Treating Young Patients With Solid Tumors
Open-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy, such as high-dose methotrexate work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Chemoprotective drugs, such as leucovorin calcium, may protect normal cells from the side effects of chemotherapy. PURPOSE: This phase I trial is studying the side effects, best way to give, and best dose of high-dose methotrexate in treating patients with solid tumors.
Timeline
- Start
- 2007-03
- Primary completion
- 2008-03
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methotrexate | Small molecule | 6000 mg/m2 | Intravenous |
| Background | Leucovorin | Small molecule | — | Intravenous |